Ltd., said Harvard Medical School presented data at the Association for Research in Vision and Ophthalmology conference in Seattle showing a major link between vascular endothelial growth factor (VEGF)-C levels and age-related macular degeneration (AMD) and that assessment of Opthea's drug development candidate, VGX-300 (a soluble form of VEGF receptor-3 that blocks VEGF-C and VEGF-D) in animal models of wet AMD confirmed its potential as a new therapy for the disease

Not one "to let the perfect be the enemy of the good," David Steensma, an associate professor at Harvard Medical School, said all trials are flawed

Kinase Has 2 Distinct Roles in Inflammation Researchers from Harvard Medical School have discovered a compound that can be used to gain new insights into how the inflammasome is activated

Despite his training at Harvard Medical School and Merck & Co

BIND, which was founded in 2007 based in work by MIT professor Robert Langer and Harvard Medical School assistant professor Omid Farokhzad, has raised nearly $90 million in venture funding

BIND, which was founded in 2007 based in work by MIT professor Robert Langer and Harvard Medical School assistant professor Omid Farokhzad, has raised nearly $90 million in venture funding

Williams, however, decided to expand her knowledge and responsibilities and moved toward medical school, stopping along the way to work with physicians on research sponsored by GlaxoSmithKline plc

In addition to the economics, BIND's ability to attract a second major partner to its medicinal nanoengineering platform represents solid validation for the biotech, launched in 2006 by prolific scientists and entrepreneurs Robert Langer, of the Massachusetts Institute of Technology, and Omid Farokhzad, of Harvard Medical School

His parody of what he learned about the autoinflammatory disease gout in medical school was that it results when "uric acid crystals make neutrophils angry

The researchers have experience in commercializing research findings – the Massachusetts Institute of Technology's Robert Langer, who is a co-corresponding author, has founded literally dozens of companies, and is an inventor on a patent estate that puts many nanotechnology companies to shame. (See BioWorld Insight, March 4, 2013.) Omid Farokhzad, of Harvard Medical School, is another co-author who has experience in bringing science to market, as the co-founder of three companies: BIND

Academic Partnership Pfizer Inc established Centers for Therapeutic Innovation (CTI) in academic institutions, typically medical schools although Sanford-Burnham Medical Research Institute is one of the sites

Sinclair is at Harvard Medical School and the senior author of the new findings, which were published in the March 8, 2013, issue of Science

Sirtris was co-founded by David Sinclair of Harvard Medical School, Christoph Westphal, then a general partner at Polaris Venture Partners and the start-up's CEO, and Greatpoint Ventures

Testing the mother after she had given birth (a birth which occurred too rapidly for test results to be available before it was all over) revealed that she was HIV-positive, and the baby was transferred to the University of Mississippi Medical School, tested with two separate blood draws, determined to be HIV positive, and put on antiretroviral drugs within the first 31 hours of its life

Salt Linked to Autoimmune-Prone Cells Three separate papers, by scientists from the Broad Institute, Harvard Medical School and Yale Medical School have identified salt as a culprit in the development of autoimmune disease

A team from Brigham and Women's Hospital and Harvard Medical School has implicated activated innate lymphoid cells in the damage caused by asthma, and identified the molecule lipoxin A as a signal that naturally dampens the activity of those cells and so might be a therapeutic target in asthma

However, the risk cannot be ignored for a treatment with marginal effectiveness," said Chair Julia Johnson, professor and chair of the department of obstetrics and gynecology and the University of Massachusetts Medical School

Reining in Innate Immunity in Asthma A team from Brigham and Women's Hospital and Harvard Medical School has implicated activated innate lymphoid cells in the damage caused by asthma, and identified the molecule lipoxin A as a signal that naturally dampens the activity of those cells and so might be a therapeutic target in asthma